bharat biotech
Jump to
144 Results Found
  • COVID-19 crisis | Bharat Biotech setting up vaccine unit in Karnataka: Deputy CM May 14, 2021 10:10 PM IST

    COVID-19 crisis | Bharat Biotech setting up vaccine unit in Karnataka: Deputy CM

    The construction work has already begun and the government has invited investors to make the vaccine in State.

  • COVID-19 Vaccine | Covaxin dispatched to various states like Assam, Gujarat: Bharat Biotech May 14, 2021 01:23 PM IST

    COVID-19 Vaccine | Covaxin dispatched to various states like Assam, Gujarat: Bharat Biotech

    Covaxin goes to Gandhinagar, Guwahati, Chennai, Hyderabad, Bengaluru and Bhuvneshwar, Bharat Biotech Co-Founder and Joint Managing Director Suchitra Ella said in a tweet.

  • Herd Immunity Part 2: Is the race a sprint or a marathon? May 14, 2021 12:10 PM IST

    Herd Immunity Part 2: Is the race a sprint or a marathon?

    In terms of Fauci’s estimated threshold (70 percent) for herd immunity, India might reach that goal by mid-November.

  • Centre invites vaccine makers to produce Covaxin, says Bharat Biotech willing to share formula May 14, 2021 09:24 AM IST

    Centre invites vaccine makers to produce Covaxin, says Bharat Biotech willing to share formula

    Covaxin can only be manufactured in the Biosafety level 3 (BSL3) labs, said Dr VK Paul.

  • As vaccines become scarce, states adopt different strategies to secure supplies May 13, 2021 06:22 PM IST

    As vaccines become scarce, states adopt different strategies to secure supplies

    While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.

  • 50 employees of Bharat Biotech test COVID-19 positive, says Joint MD Suchitra Ella May 13, 2021 01:49 PM IST

    50 employees of Bharat Biotech test COVID-19 positive, says Joint MD Suchitra Ella

    Ella said as many as 18 states received Covaxin though in smaller shipments.

  • COVID-19 vaccine | DCGI approves Phase II/III clinical trial of Covaxin on 2-18 year-olds May 13, 2021 11:01 AM IST

    COVID-19 vaccine | DCGI approves Phase II/III clinical trial of Covaxin on 2-18 year-olds

    The Drugs Controller General of India (DCGI) has approved Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years.

  • Bharat Biotech says can't provide additional Covaxin doses to Delhi: Manish Sisodia May 12, 2021 12:57 PM IST

    Bharat Biotech says can't provide additional Covaxin doses to Delhi: Manish Sisodia

    The stock of Covaxin in Delhi has finished and as a result around 100 vaccination centres set up in 17 schools have been closed, he said.

  • COVID-19 crisis | Transfer Covaxin know-how to interested firms, Andhra CM Jagan Mohan Reddy tells PM Modi May 11, 2021 06:43 PM IST

    COVID-19 crisis | Transfer Covaxin know-how to interested firms, Andhra CM Jagan Mohan Reddy tells PM Modi

    The CM said that the average count of cases per day in state over the last seven days stood at 20,300 and as of May 11, the state had 1,86,695 active cases.

  • Bharat Biotech commences direct supply of 'Covaxin' to 14 states May 10, 2021 12:44 PM IST

    Bharat Biotech commences direct supply of 'Covaxin' to 14 states

    The Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to the states based on the allocations received by the central government.

  • Covid vaccine production and availability: What we know so far May 04, 2021 02:23 PM IST

    Covid vaccine production and availability: What we know so far

    So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.

  • Covaxin effective against Brazil, UK and Indian 'double mutant' COVID-19 strain: ICMR-NIV study May 04, 2021 08:52 AM IST

    Covaxin effective against Brazil, UK and Indian 'double mutant' COVID-19 strain: ICMR-NIV study

    The B.1.617 variant is also being called a 'double mutant' or the 'Indian strain'.

  • Govt Explores Possibility of Producing Covaxin Abroad Amid Supply Crunch: Report May 01, 2021 10:07 AM IST

    Govt Explores Possibility of Producing Covaxin Abroad Amid Supply Crunch: Report

    Covaxin has received Emergency Use Authorisation in several countries across the globe with another 60 in process.

  • Bharat Biotech reduces Covaxin price for states to Rs 400 per dose Apr 29, 2021 05:55 PM IST

    Bharat Biotech reduces Covaxin price for states to Rs 400 per dose

    Bharat Biotech had earlier set Covaxin’s price at Rs 600 per dose for state governments. The company decided to reduce the price in view of the enormous challenges the second wave of the pandemic has posed for the public healthcare systems.

  • Vaccination deals between Serum Institute, Bharat Biotech and states: What we know so far Apr 29, 2021 11:51 AM IST

    Vaccination deals between Serum Institute, Bharat Biotech and states: What we know so far

    COVID-19 Second Wave Vaccine Drive: It has been a Covishield show so far as state governments make a beeline for developer SII’s office. Bharat Biotech needs to significantly ramp up capacity of Covaxin.

  • PIL filed in Bombay HC seeks sale of vaccines by SII, Bharat Biotech at Rs 150 Apr 28, 2021 01:06 PM IST

    PIL filed in Bombay HC seeks sale of vaccines by SII, Bharat Biotech at Rs 150

    The PIL, filed on April 24 by advocate Fayzan Khan and three law students, said the vaccine is presumed to be an essential commodity and hence its management and distribution cannot be left in the hands of private companies.

  • COVID-19 vaccines | Bharat Biotech's Covaxin found to neutralise '617' coronavirus variant: Dr Anthony Fauci Apr 28, 2021 07:53 AM IST

    COVID-19 vaccines | Bharat Biotech's Covaxin found to neutralise '617' coronavirus variant: Dr Anthony Fauci

    White House chief medical adviser Dr Anthony Fauci said COVID-19 vaccination could be a very important antidote to the pandemic difficulty being seen India.

  • Centre asks Serum Institute, Bharat Biotech to lower COVID-19 vaccine prices Apr 26, 2021 07:41 PM IST

    Centre asks Serum Institute, Bharat Biotech to lower COVID-19 vaccine prices

    The SII has priced the Covishield vaccine at Rs 400 for states and Rs 600 private hospitals, whereas, the Bharat Biotech has decided to sell the jabs at Rs 600 to states and Rs 1,200 to private hospitals.

  • Centre should share some financial burden of states' vaccine procurement, experts say Apr 25, 2021 06:46 PM IST

    Centre should share some financial burden of states' vaccine procurement, experts say

    Former CEA Arvind Subramanian said that centre should bear entire cost of vaccine procurement by state. Other economists partly agree and say that part of the Rs 35,000 crore vaccination budget should be shared with states

  • Bharat Biotech's Covaxin to be sold at Rs 600/dose to states, Rs 1,200 to private hospitals Apr 24, 2021 10:15 PM IST

    Bharat Biotech's Covaxin to be sold at Rs 600/dose to states, Rs 1,200 to private hospitals

    Bharat Biotech further announced that it will also export Covaxin and the export price of the vaccine would be between $15-$20, i.e., between Rs 1,100 to Rs 1,500 per dose, approximately.

  • Explained | How the new vaccination drive is expected to roll out Apr 23, 2021 11:16 AM IST

    Explained | How the new vaccination drive is expected to roll out

    On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.

  • COVID-19 update | Covishield comprises over 90% of 12.76 crore vaccines administered so far Apr 21, 2021 05:08 PM IST

    COVID-19 update | Covishield comprises over 90% of 12.76 crore vaccines administered so far

    Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India.

  • Bharat Biotech Covaxin demonstrates 78% efficacy in Phase-3 interim analysis Apr 21, 2021 03:19 PM IST

    Bharat Biotech Covaxin demonstrates 78% efficacy in Phase-3 interim analysis

    Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 percent against mild, moderate, and severe COVID-19 disease, the company said.

  • COVID-19 update | Bharat Biotech announces COVAXIN capacity expansion to support vaccination campaigns in India, worldwide Apr 20, 2021 03:10 PM IST

    COVID-19 update | Bharat Biotech announces COVAXIN capacity expansion to support vaccination campaigns in India, worldwide

    The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach over 700 million doses per year, which are one of the largest production capacities for inactivated viral vaccines worldwide.

  • Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech Apr 19, 2021 09:19 PM IST

    Govt gives ‘advance’ of around Rs 4,500 crore to Serum Institute of India, Bharat Biotech

    “The Finance Ministry today has relaxed the general financial rules and permitted the Ministry of Health to pay, if they so wish, to make advance payment to vaccine suppliers, without a bank guarantee. I believe the Health Ministry is already doing so,” a top official told Moneycontrol

Sections